Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan J Coffey

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Nature Reviews. Nephrology|January 22, 2024
Metabolic alterations in hereditary and sporadic renal cell carcinomaNathan J Coffey, M Celeste Simon
Advances in Experimental Medicine and Biology|May 20, 2021
The Heterogeneity of Lipid Metabolism in CancerJoshua K Park, Nathan J Coffey, Aaron Limoges, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 24, 2018
Synthesis of <sup>13</sup> C<sub>6</sub> -labeled, dual-target inhibitor of cannabinoid-1 receptor (CB<sub>1</sub> R) and inducible nitric oxide synthase (iNOS)Malliga R Iyer, Resat Cinar, Nathan J Coffey, et al.
Advances in Experimental Medicine and Biology|June 28, 2018
The Heterogeneity of Lipid Metabolism in CancerJoshua K Park, Nathan J Coffey, Aaron Limoges, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 26, 2017
Synthesis of S-2-((S)-3-(4-chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-(methyl-d<sub>3</sub> )butanamide-d<sub>5</sub> , octadeuterated JD5037Malliga R Iyer, Resat Cinar, Nathan J Coffey, et al.
Scientific Reports|February 13, 2021
Cholesterol as a modulator of cannabinoid receptor CB<sub>2</sub> signalingAlexei Yeliseev, Malliga R Iyer, Thomas T Joseph, et al.
Journal of Medicinal Chemistry|January 14, 2017
Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB<sub>1</sub>R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver FibrosisMalliga R Iyer, Resat Cinar, Alexis Katz, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
HIF2α inhibits glutaminase clustering in mitochondria to sustain growth of clear cell Renal Cell CarcinomaWencao Zhao, Boyoung Kim, Nathan J Coffey, et al.
Diabetes, Obesity & Metabolism|November 7, 2017
Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathyTony Jourdan, Joshua K Park, Zoltán V Varga, et al.
The Journal of Cell Biology|December 9, 2015
Ephrin-A3 promotes and maintains slow muscle fiber identity during postnatal development and reinnervationDanny A Stark, Nathan J Coffey, Hannah R Pancoast, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Nature Reviews. Nephrology|January 22, 2024
Metabolic alterations in hereditary and sporadic renal cell carcinomaNathan J Coffey, M Celeste Simon
Advances in Experimental Medicine and Biology|May 20, 2021
The Heterogeneity of Lipid Metabolism in CancerJoshua K Park, Nathan J Coffey, Aaron Limoges, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 24, 2018
Synthesis of <sup>13</sup> C<sub>6</sub> -labeled, dual-target inhibitor of cannabinoid-1 receptor (CB<sub>1</sub> R) and inducible nitric oxide synthase (iNOS)Malliga R Iyer, Resat Cinar, Nathan J Coffey, et al.
Advances in Experimental Medicine and Biology|June 28, 2018
The Heterogeneity of Lipid Metabolism in CancerJoshua K Park, Nathan J Coffey, Aaron Limoges, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 26, 2017
Synthesis of S-2-((S)-3-(4-chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-(methyl-d<sub>3</sub> )butanamide-d<sub>5</sub> , octadeuterated JD5037Malliga R Iyer, Resat Cinar, Nathan J Coffey, et al.
Scientific Reports|February 13, 2021
Cholesterol as a modulator of cannabinoid receptor CB<sub>2</sub> signalingAlexei Yeliseev, Malliga R Iyer, Thomas T Joseph, et al.
Journal of Medicinal Chemistry|January 14, 2017
Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB<sub>1</sub>R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver FibrosisMalliga R Iyer, Resat Cinar, Alexis Katz, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
HIF2α inhibits glutaminase clustering in mitochondria to sustain growth of clear cell Renal Cell CarcinomaWencao Zhao, Boyoung Kim, Nathan J Coffey, et al.
Diabetes, Obesity & Metabolism|November 7, 2017
Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathyTony Jourdan, Joshua K Park, Zoltán V Varga, et al.
The Journal of Cell Biology|December 9, 2015
Ephrin-A3 promotes and maintains slow muscle fiber identity during postnatal development and reinnervationDanny A Stark, Nathan J Coffey, Hannah R Pancoast, et al.
Pageof 3